Back
Viking Therapeutics, Inc. Stock Predictions
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
19
VKTX
Viking Therapeutics, Inc.
Last Price:
$28.45
Seasonality Move:
21.74%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comViking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 66.3% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $26.29. The Score for VKTX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 66.3% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
19
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
43.15
52-Week Low:
18.92
Prediction Charts
Market Cap:
3B
Price in USD:
26.29
Volume:
5.8M
Beta:
1.33
Technical Analysis
SMA50:
33.99
SMA100:
33.30
SMA200:
31.23
52-Wk Change:
-21.52%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 26.29 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-16 | 31.98 | 33.92 | 34.28 | 31.71 |
| Jan-20 | 32.78 | 33.52 | 34.06 | 32.56 |
| Jan-21 | 33.63 | 33.38 | 33.98 | 32.42 |
| Jan-22 | 33.45 | 34.09 | 34.99 | 33.26 |
| Jan-23 | 33.81 | 32.22 | 34.41 | 32.05 |
| Jan-26 | 31.93 | 31.73 | 32.72 | 31.49 |
| Jan-27 | 31.75 | 31.40 | 32.14 | 31.20 |
| Jan-28 | 31.49 | 30.41 | 31.49 | 30.07 |
| Jan-29 | 30.28 | 30.24 | 30.81 | 29.92 |
| Jan-30 | 30.34 | 29.04 | 30.59 | 28.95 |
| Feb-2 | 28.65 | 29.92 | 30.25 | 28.55 |
| Feb-3 | 30.40 | 29.41 | 30.80 | 28.56 |
| Feb-4 | 29.53 | 29.56 | 29.66 | 28.01 |
| Feb-5 | 28.11 | 26.29 | 28.64 | 25.77 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.28 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.